What is the upside for AcelRx Pharmaceuticals'stock?
Their forecasts range from $5.00 to $5.00. On average, they anticipate AcelRx Pharmaceuticals' stock price to reach $5.00 in the next year. This suggests a possible upside of 863.4% from the stock's current price. View analysts' price targets for AcelRx Pharmaceuticals or view top-rated stocks among Wall Street analysts.
Should you pay close attention to Ardelyx (ardx) stock?
Investors need to pay close attention to Ardelyx (ARDX) stock based on the movements in the options market lately.
What are analysts'price targets for AcelRx Pharmaceuticals'stock?
1 equities research analysts have issued 12-month price objectives for AcelRx Pharmaceuticals' shares. Their forecasts range from $5.00 to $5.00. On average, they anticipate AcelRx Pharmaceuticals' stock price to reach $5.00 in the next year. This suggests a possible upside of 863.4% from the stock's current price.
Where can I buy acrx shares?
Shares of ACRX can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Compare Top Brokerages Here.
Is ARDX a good stock to buy?
Out of 5 analysts, 3 (60%) are recommending ARDX as a Strong Buy, 0 (0%) are recommending ARDX as a Buy, 2 (40%) are recommending ARDX as a Hold, 0 (0%) are recommending ARDX as a Sell, and 0 (0%) are recommending ARDX as a Strong Sell.
Will ardelyx go up?
Ardelyx Inc (NASDAQ:ARDX) The 6 analysts offering 12-month price forecasts for Ardelyx Inc have a median target of 4.00, with a high estimate of 12.00 and a low estimate of 1.00. The median estimate represents a +586.46% increase from the last price of 0.58.
Is Ardelyx a buy?
Ardelyx has received a consensus rating of Buy. The company's average rating score is 2.60, and is based on 3 buy ratings, 2 hold ratings, and no sell ratings.
Will ARDX get FDA approval?
(NASDAQ: ARDX), a specialized biopharmaceutical company focused on developing innovative first-in-class medicines to improve treatment for people with cardiorenal diseases, today announced that the U.S. Food and Drug Administration has approved IBSRELA® (tenapanor), a 50 mg, twice daily oral pill for the treatment of ...
What is Ardelyx Inc?
What time do you trade in the pre market?
Ardelyx Inc is a biotechnology company focused on the discovery, development, and commercialization of molecule and polymeric therapeutics to treat the gastrointestinal tract and cardiorenal diseases. The company has a proprietary drug discovery and design platform. Its lead product candidate is tenapanor, which aims to reduce the absorption of dietary sodium and phosphorus for the treatment of kidney disease, irritable bowel syndrome with constipation, an
Does market cap include convertible securities?
Investors may trade in the Pre-Market (4:00-9:30 a.m. ET) and the After Hours Market (4:00-8:00 p.m. ET). Participation from Market Makers and ECNs is strictly voluntary and as a result, these sessions may offer less liquidity and inferior prices. Stock prices may also move more quickly in this environment.
Recently Viewed Tickers
It does not include securities convertible into the common equity securities. "Market Cap" is derived from the last sale price for the displayed class of listed securities and the total number of shares outstanding for both listed and unlisted securities (as applicable).
Ardelyx Inc
Visit a quote page and your recently viewed tickers will be displayed here.
How much does Aditxt invest in?
Ardelyx, Inc. is a biopharmaceutical company, which engages in the research, development and commercialization of medicine for the treatment of cardiorenal diseases. Its product portfolio includes tenapanor, which is an experimental medication that works exclusively in the gut and is in late-stage clinical development.
What is Aditx Therapeutics?
Aditxt is targeting a capital investment of $31.5 million over three years to scale up its state-of-the-art immune monitoring center, including projected new jobs, laboratory equipment, and construction.
Where is Aditxt located?
Aditx Therapeutics, Inc. (Aditxt) (the "Company") (Nasdaq: ADTX), a biotech innovation company focused on improving the health of the immune system , today announced that HealthBar will be offering AditxtScore™ for COVID-19 throughout the State of Michigan.
When will Aditx join Russell Microcap?
Aditxt (Aditx Therapeutics, Inc.) (Nasdaq: ADTX), a biotech innovation company focused on improving the health of the immune system, today announced plans to build a high-capacity AditxtScore™ Center in Richmond, VA in the second half of 2021. Aditxt is targeting a capital investment of $31.5 million over three years to scale up its state-of-the-art immune monitoring center, including projected new jobs, laboratory equipment, and construction. The announcement was made at a joint press conference with Governor Ralph Northam, Richmond Mayor Levar Stoney and other local business executives and political officials.
When will hedge funds return?
("Aditxt") (NASDAQ: ADTX), a biotech innovation company with a mission to improve the health of the immune system, today announced that it is set to join the Russell Microcap® Index, effective after the US market opens on June 28, 2021.
When is the Agile Therapeutics fireside chat 2021?
Most investors who decided to stick with hedge funds after a rough 2018 recouped their losses by the end of the fourth quarter of 2019.
AcelRx Pharmaceuticals Announces Publication of Clinical Data on the Use of Sufentanil Sublingual Tablet during Awake Plastic Surgery Procedures
Chairman and Chief Executive Officer Al Altomari is scheduled to participate in a fireside chat on Tuesday, June 1, 2021 at 10:20 a.m. Eastern Time. The fireside chat will be webcast live and can be accessed in the Events and Presentations section of the Agile Therapeutics website or by clicking here: https://wsw.com/webcast/blair58/agrx/1940510. ...
When Will AcelRx Pharmaceuticals, Inc. (NASDAQ:ACRX) Breakeven?
AcelRx Pharmaceuticals, Inc.
Edmonds Duncan Registered Investment Advisors, LLC Buys VanEck Vectors Semiconductor ETF, ..
AcelRx Pharmaceuticals, Inc. ( NASDAQ:ACRX ) is possibly approaching a major achievement in its business, so we would...
About AcelRx Pharmaceuticals
Investment company Edmonds Duncan Registered Investment Advisors, LLC (Current Portfolio) buys VanEck Vectors Semiconductor ETF, Erasca Inc, Concentrix Corp, Tenet Healthcare Corp, Palo Alto Networks Inc, sells WisdomTree Japan Hedged Equity Fund, PayPal Holdings Inc, Alphabet Inc, Boeing Co, Walmart Inc during the 3-months ended 2021Q4, according to the most recent filings of the investment company, Edmonds Duncan Registered Investment Advisors, LLC..
AcelRx Pharmaceuticals (NASDAQ:ACRX) Frequently Asked Questions
AcelRx Pharmaceuticals, Inc. engages in the development and commercialization of therapies use in medically supervised settings. The firm's portfolio includes DSUVIA, DZUVEO, Zalviso, ARX-02 and ARX-03. The company was founded by Thomas A. Schreck and Pamela Pierce Palmer on July 13, 2005 and is headquartered in Redwood City, CA.
